Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion type Assertion NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_head.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion wasGeneratedBy ECO_0000203 NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_provenance.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion wasDerivedFrom befree-2016 NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_provenance.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion SIO_000772 14633710 NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_provenance.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion evidence source_evidence_literature NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_provenance.
- NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_assertion description "[Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421702.RAfvoalUfqQiVWQq8-LTnQJALgv4pphlNnC4Pw2P5UIrk130_provenance.